194 related articles for article (PubMed ID: 24375894)
1. Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?
Martinez S; Khakoo Y; Gilheeney S; Kramer K; Wolden S; Souweidane M; Dunkel IJ
Pediatr Blood Cancer; 2014 May; 61(5):853-4. PubMed ID: 24375894
[TBL] [Abstract][Full Text] [Related]
2. Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors.
Cheung V; Segal D; Gardner SL; Zagzag D; Wisoff JH; Allen JC; Karajannis MA
J Neurooncol; 2016 Sep; 129(3):541-544. PubMed ID: 27406584
[TBL] [Abstract][Full Text] [Related]
3. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
[TBL] [Abstract][Full Text] [Related]
4. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
[TBL] [Abstract][Full Text] [Related]
5. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
6. [Germ-cell tumors of the central nervous system in childhood: retrospective study of 13 patients].
Voirin J; Klein O; Chastagner P; Moret C; Vignaud JM; Auque J; Marchal JC
Neurochirurgie; 2008 Apr; 54(2):55-62. PubMed ID: 18355878
[TBL] [Abstract][Full Text] [Related]
7. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy.
Keskin S; Ekenel M; Başaran M; Bavbek S
Am J Clin Oncol; 2012 Aug; 35(4):369-72. PubMed ID: 22814307
[TBL] [Abstract][Full Text] [Related]
10. Correlation of endoscopic biopsy with tumor marker status in primary intracranial germ cell tumors.
Luther N; Edgar MA; Dunkel IJ; Souweidane MM
J Neurooncol; 2006 Aug; 79(1):45-50. PubMed ID: 16598424
[TBL] [Abstract][Full Text] [Related]
11. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features.
Shaaban AM; Rezvani M; Elsayes KM; Baskin H; Mourad A; Foster BR; Jarboe EA; Menias CO
Radiographics; 2014; 34(3):777-801. PubMed ID: 24819795
[TBL] [Abstract][Full Text] [Related]
12. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
13. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
[TBL] [Abstract][Full Text] [Related]
14. A need for cautious interpretation of elevated serum germ cell tumor markers in children. Review and own experiences.
Drozynska E; Bien E; Polczynska K; Stefanowicz J; Zalewska-Szewczyk B; Izycka-Swieszewska E; Ploszynska A; Krawczyk M; Karpinsky G
Biomark Med; 2015; 9(9):923-32. PubMed ID: 26329804
[TBL] [Abstract][Full Text] [Related]
15. The use of serum tumor markers in the management of patients with malignancy.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
[No Abstract] [Full Text] [Related]
16. Serum markers in germ cell neoplasms.
Bartlett NL; Freiha FS; Torti FM
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
[TBL] [Abstract][Full Text] [Related]
17. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
[TBL] [Abstract][Full Text] [Related]
18. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
[TBL] [Abstract][Full Text] [Related]
19. [The value of tumor markers in germ cell tumors].
de Goede EC; Vandertop WP; Struikmans H; ter Bruggen JP
Tijdschr Kindergeneeskd; 1991 Jun; 59(3):85-7. PubMed ID: 1713713
[TBL] [Abstract][Full Text] [Related]
20. [Mixed tumors of the pineal area. Diagnosis and therapy consisting of secreting germ cell tumor].
Hilker R; Mielke R; Berthold F; Schröder R; Heiss WD
Nervenarzt; 1998 Jun; 69(6):519-24. PubMed ID: 9673977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
